To analyze the characteristics, health resource use and medical costs of patients with hypertension among China Basic Medical Insurance (BMI) participants in 2014.Methods:
This retrospective analysis used the data of 33 cities from China health insurance database in 2014. Patients aged ≥ 18 years and diagnosed with hypertension were identified. Those with the diagnosis of cancer or organ failure were excluded. Totally 298,263 patients were identified.Results:
1) Of all patients, the mean age was 62.5 years and 49.5% were male. Most of the patients were covered under the urban employee BMI (92.1%) and from Eastern China (91.5%). The top three comorbidities were coronary heart disease (27.2%), diabetes (20.3%) and stroke (7.1%). 2) Of all patients, 86.3% received only outpatient treatment and 13.8% received inpatient treatment. Totally 5.77 million outpatient visits happened (i.e. 19.7 visits per patient on average), and 33.7% happened in tertiary hospitals. Besides, 64,594 hospitalizations happened totally (i.e. 1.6 admissions per hospitalized patient on average), of which 54.7% were in tertiary hospitals. As to the utilization of antihypertensive drugs, only 46% received ≥ 2 prescriptions. 3) The all-cause medical expenses for all patients was RMB ¥1.9 billion totally (59% for outpatient and 41% for hospitalizations). Of the total costs, only 7.6% was spent on antihypertensive drugs. The average cost was ¥286.4 per outpatient visit and ¥9210.4 per hospitalization for patients with a primary diagnosis of hypertension.Conclusion:
Hypertension patients caused substantial costs, most of which happened in tertiary hospitals, especially the costs for hospitalization. The cost of antihypertensive drugs seemed not burdensome, but the utilization seemed suboptimal.